Washington, D.C. 20549







Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): February 6, 2019


(Exact name of registrant as specified in its charter)


Delaware   001-36529   22-3832302

(State or other jurisdiction

of incorporation)



File Number)


(IRS Employer

Identification No.)


7 Clyde Road, Somerset, New Jersey, 08873
(Address of principal executive offices, zip code)


(732) 873-5133

(Registrant’s telephone number, including area code)


Medical Transcription Billing, Corp.
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company [X]


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [X]






Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.


On February 6, 2019, Medical Transcription Billing, Corp. (the “Company”) filed a Certificate of Amendment (the “Amendment”) to its Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to change its corporate name to “MTBC, Inc.”, effective February 6, 2019. A copy of the Amendment is attached as Exhibit 3.1 hereto and incorporated by reference.


The Company’s NASDAQ ticker symbols MTBC and MTBCP, will remain unchanged. Pursuant to the name change, the Company’s CUSIPs for its common and preferred stock will also be changed to 55378G102 and 55378G201, respectively, which is pending effectiveness.


Item 9.01 Financial Statements and Exhibits


Exhibit No.   Description


  Certificate of Amendment of Amended and Restated Certificate of Incorporation.
99.1   Press Release issued February 7, 2019, announcing the name change.






Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


  MTBC, Inc.
Date: February 7, 2019 By: /s/ Stephen Snyder
    Stephen Snyder
    Chief Executive Officer









Medical Transcription Billing, Corp., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware does hereby certify:


FIRST: Article I of the Amended and Restated Certificate of Incorporation of this corporation is hereby amended and replaced to read in its entirety as follows:


The name of this corporation is MTBC, Inc. (the “Corporation”).


SECOND: That said amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.


IN WITNESS WHEREOF, said corporation has caused this certificate to be signed this 6th day of February, 2019.


  By: /s/ Stephen Snyder
  Name: Stephen Snyder
  Title: Chief Executive Officer






Medical Transcription Billing, Corp. Officially Changes Company Name to MTBC, Inc.


SOMERSET, N.J., February 7, 2019 (Globe Newswire) – MTBC (NASDAQ:MTBC) (NASDAQ: MTBCP), a leading provider of cloud-based healthcare IT solutions and services, today announced the official change of its company name from “Medical Transcription Billing, Corp.” to “MTBC, Inc.” effective February 6, 2019. The company’s NASDAQ ticker symbol for its common stock will remain “MTBC” and the ticker symbol for its preferred stock will remain “MTBCP.”


“While our earliest days were focused on providing transcription and manual medical billing to small practices, over the last 18 years we’ve evolved into one of the nation’s leading providers of proprietary healthcare IT solutions, analytics and cloud-based revenue cycle management services to hospitals and independent practices of all sizes and specialties,” said Mahmud Haq, MTBC’s founder and executive chairman. “As our company has evolved, we’ve become known in the industry as “MTBC,” rather than “Medical Transcription Billing,” so we’re pleased to officially update our name to better reflect our company mission.”


MTBC’s highly rated cloud-based and mobile platform includes proprietary electronic health records, practice management, revenue cycle management, business intelligence, patient engagement, insurance enrollment, clearinghouse, EDI solutions, and a group purchasing organization. Its leading solutions are utilized by more than 10,000 healthcare providers throughout the United States to streamline workflows, increase revenues and reduce expenses.


MTBC is a Delaware Corporation that maintains its headquarters in Somerset, New Jersey and employs approximately 2,400 team members worldwide, including more than 350 IT and R&D professionals. The company has three subsidiaries in the United States and two subsidiaries in Asia.


About MTBC


MTBC is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers throughout the United States. Our integrated Software-as-a-Service (SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC’s common stock trades on the NASDAQ Capital Market under the ticker symbol “MTBC,” and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol “MTBCP.”


For additional information, please visit our website at www.mtbc.com.






Company and Investor Contact:

Bill Korn

Chief Financial Officer

MTBC, Inc.


(732) 873-5133


Investor Contact:

Matt Kreps, Managing Director

Darrow Associates Investor Relations


(214) 597-8200